Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In
Timothy L. Zisman, MD, MPH
Associate Professor
Biography

Dr. Zisman is a UW Associate Professor in the Division of Gastroenterology. His clinical and research insterests include cancer and dysplasia in Inflammatory Bowel Disease; Infections in Inflammatory Bowel Disease; and Outcomes in severe ulcerative colitis.

Recent Publications
Displaying 20 Most Recent Publications from PubMed

March 2018. Obesity and inflammatory bowel disease: diagnostic and therapeutic implications. Swanson SM, Harper J, Zisman TL. Curr Opin Gastroenterol. 2018 Mar;34(2):112-119. doi: 10.1097/MOG.0000000000000422.

June 2017. The microbiota in inflammatory bowel disease: current and therapeutic insights. Lane ER, Zisman TL, Suskind DL. J Inflamm Res. 2017 Jun 10;10:63-73. doi: 10.2147/JIR.S116088. eCollection 2017.

September 2016. Interaction of obesity and inflammatory bowel disease. Harper JW, Zisman TL. World J Gastroenterol. 2016 Sep 21;22(35):7868-81. doi: 10.3748/wjg.v22.i35.7868. Review.

July 2016. GUTSS: An Alignment-Free Sequence Comparison Method for Use in Human Intestinal Microbiome and Fecal Microbiota Transplantation Analysis. Brittnacher MJ, Heltshe SL, Hayden HS, Radey MC, Weiss EJ, Damman CJ, Zisman TL, Suskind DL, Miller SI. PLoS One. 2016 Jul 8;11(7):e0158897. doi: 10.1371/journal.pone.0158897. eCollection 2016.

July 2016. The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Vindigni SM, Zisman TL, Suskind DL, Damman CJ. Therap Adv Gastroenterol. 2016 Jul;9(4):606-25. doi: 10.1177/1756283X16644242. Epub 2016 Apr 19. Review.

August 2015. Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis. Damman CJ, Brittnacher MJ, Westerhoff M, Hayden HS, Radey M, Hager KR, Marquis SR, Miller SI, Zisman TL. PLoS One. 2015 Aug 19;10(8):e0133925. doi: 10.1371/journal.pone.0133925. eCollection 2015.

September 2013. Increased Body Mass Index Is Associated with Earlier Time to Loss of Response to Infliximab in Patients with Inflammatory Bowel Disease. Harper JW, Sinanan MN, Zisman TL. Inflamm Bowel Dis. 2013 Sep;19(10):2118-24. doi: 10.1097/MIB.0b013e31829cf401.

December 2012. Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines. Zisman TL, Bronner MP, Rulyak S, Kowdley KV, Saunders M, Lee SD, Ko C, Kimmey MB, Stevens A, Maurer J, Brentnall TA. Inflamm Bowel Dis. 2012 Dec;18(12):2240-6. doi: 10.1002/ibd.22912. Epub 2012 Apr 16.

October 2012. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Damman CJ, Miller SI, Surawicz CM, Zisman TL. Am J Gastroenterol. 2012 Oct;107(10):1452-9. doi: 10.1038/ajg.2012.93.

January 2010. Novel diagnostic and prognostic modalities in inflammatory bowel disease. Zisman TL, Rubin DT. Med Clin North Am. 2010 Jan;94(1):155-78.

December 2009. Novel diagnostic and prognostic modalities in inflammatory bowel disease. Zisman TL, Rubin DT Gastroenterol Clin North Am. 2009 Dec;38(4):729-52

October 2008. Identification of patients at increased risk for colorectal cancer in an open access endoscopy center. Nathanson JW, Zisman TL, Julian C, McCaffrey S, Rubin DT. J Clin Gastroenterol. 2008 Oct;42(9):1025-31. doi: 10.1097/MCG.0b013e3181468613.

May 2008. Colorectal cancer and dysplasia in inflammatory bowel disease. Zisman TL, Rubin DT. World J Gastroenterol. 2008 May 7;14(17):2662-9.

October 2007. Current and future therapies for inflammatory bowel disease. Zisman TL, Kane SV. Expert Rev Gastroenterol Hepatol. 2007 Oct;1(1):89-100. doi: 10.1586/17474124.1.1.89.

June 2007. Pharmacoeconomics and quality of life of current and emerging biologic therapies for inflammatory bowel disease. Zisman TL, Cohen RD. Curr Treat Options Gastroenterol. 2007 Jun;10(3):185-94.

March 1998. Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells. Hasan AA, Zisman T, Schmaier AH. Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3615-20.

Contact Info
Education

M.D., Virginia Commonwealth University, Richmond, VA

M.P.H., Harvard University, Boston, MA

Residency, Department of Internal Medicine, University of Chicago Medical Center, Chicago, IL

Fellow, Department of Medicine, Division of Gastroenterology, University of Chicago Medical Center, Chicago, IL

©2016-2018 University of Washington Division of Gastroenterology
1959 NE Pacific St., Box 356424, Seattle, WA 98195-6424
Contact Us | Privacy | Terms | Copyright & Disclaimer